VivoSim Labs (VIVS) Non-Current Deffered Revenue (2013 - 2019)
VivoSim Labs (VIVS) posted Non-Current Deffered Revenue of $588000.0 for Q1 2019, down 2.0% on a QoQ basis from $600000.0 in Q4 2018, and up 4.26% year-over-year from $564000.0 in Q1 2018.
Powered by 
Analysis
VivoSim Labs (VIVS) Non-Current Deffered Revenue (2013 - 2019) Analysis & Trends
VivoSim Labs has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $588000.0 in Q1 2019.
- On a quarterly basis, Non-Current Deffered Revenue rose 4.26% year-over-year to $588000.0 in Q1 2019; TTM through Mar 2019 was $588000.0, a 4.26% increase from a year earlier, with the FY2019 full-year figure at $588000.0, up 4.26% from the prior year.
- Non-Current Deffered Revenue was $588000.0 for Q1 2019 at VivoSim Labs, down from $600000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $905000.0 in Q1 2016, with the low at $7000.0 in Q3 2015.
- Average Non-Current Deffered Revenue over 5 years is $556750.0, with a median of $606500.0 recorded in 2017.
- The sharpest annual moves came in 2016 and 2018: Non-Current Deffered Revenue surged 11742.86% in 2016, then retreated 29.8% in 2018.
- Over 5 years, Non-Current Deffered Revenue stood at $7000.0 in 2015, then soared by 11128.57% to $786000.0 in 2016, then declined by 22.01% to $613000.0 in 2017, then declined by 2.12% to $600000.0 in 2018, then declined by 2.0% to $588000.0 in 2019.
- The last three Non-Current Deffered Revenue figures came in at $588000.0 (Q1 2019), $600000.0 (Q4 2018), and $464000.0 (Q3 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 158.90 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 76.54 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 588,000.00 |
| Dec 31, 2018 | 600,000.00 |
| Sep 30, 2018 | 464,000.00 |
| Jun 30, 2018 | 516,000.00 |
| Mar 31, 2018 | 564,000.00 |
| Dec 31, 2017 | 613,000.00 |
| Sep 30, 2017 | 661,000.00 |
| Jun 30, 2017 | 707,000.00 |
| Mar 31, 2017 | 749,000.00 |
| Dec 31, 2016 | 786,000.00 |
| Sep 30, 2016 | 829,000.00 |
| Jun 30, 2016 | 868,000.00 |
| Mar 31, 2016 | 905,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Jun 30, 2015 | 19,000.00 |
| Mar 31, 2015 | 32,000.00 |
| Dec 31, 2014 | 44,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Mar 31, 2014 | 4,000.00 |